Zota Health Care Ltd

Zota Health Care Ltd has exhibited a notable shift in price momentum, with technical indicators signalling a complex interplay of bullish and bearish trends. Despite a strong day change of 4.73%, the stock’s overall technical profile remains mixed, reflecting sideways momentum after a period of mild bearishness. This analysis delves into the latest technical parameters, including MACD, RSI, moving averages, and other key indicators, providing a comprehensive view for investors navigating this small-cap pharmaceutical player.

Zota Health Care Ltd has exhibited a notable shift in its technical momentum, transitioning from a sideways trend to a mildly bearish stance. Despite a recent uptick in price, a detailed analysis of key technical indicators such as MACD, RSI, moving averages, and volume-based metrics reveals a complex picture for investors navigating this pharmaceuticals and biotechnology small-cap stock.

Zota Health Care Ltd has exhibited a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend, reflecting a complex interplay of bullish and bearish signals across key technical indicators. Despite a strong day change of 4.36%, the company’s overall technical profile remains mixed, warranting a cautious approach from investors amid evolving market dynamics.

Zota Health Care Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 04 March 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 14 June 2026, providing investors with the latest insights into the company’s performance and outlook.

Zota Health Care Ltd reported its quarterly results for March 2026, revealing a complex financial picture marked by record net sales and operating profit margins, yet persistent net losses and rising interest expenses. Despite improvements in some key metrics, the company’s overall financial trend has shifted from positive to flat, prompting a downgrade in its Mojo Grade to Strong Sell.

Zota Health Care Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 04 March 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 03 June 2026, providing investors with the latest insights into the company’s performance and outlook.

Zota Health Care Ltd., the Surat-based pharmaceutical manufacturer, reported a consolidated net loss of ₹14.17 crores for Q4 FY26, marking a deterioration of 51.97% quarter-on-quarter despite recording its highest-ever quarterly revenue of ₹163.18 crores. The stock, trading at ₹1,192.60 with a market capitalisation of ₹4,204 crores, has declined 1.95% following the results announcement, extending its six-month downtrend of 29.23%.

Zota Health Care Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 04 Mar 2026, reflecting a reassessment of the stock’s outlook. However, the analysis and financial metrics presented here are based on the company’s current position as of 23 May 2026, providing investors with the latest insights into its performance and prospects.

Zota Health Care Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 04 Mar 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 12 May 2026, providing investors with the latest insights into the company’s performance and outlook.

Zota Health Care Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, transitioning from a sideways trend to a mildly bearish stance. Despite this, several technical indicators present a mixed picture, reflecting both bullish and bearish signals across weekly and monthly timeframes, complicating the outlook for investors.

Zota Health Care Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Despite a modest day gain of 0.41%, the stock’s technical indicators reveal a sideways trend emerging from a previously mildly bearish stance, prompting a reassessment of its near-term price trajectory.

Zota Health Care Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 04 Mar 2026. However, the analysis and financial metrics presented here reflect the stock’s current position as of 01 May 2026, providing investors with the latest insights into the company’s fundamentals, valuation, financial trends, and technical outlook.

Zota Health Care Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 04 March 2026. However, the analysis and financial metrics presented here reflect the stock’s current position as of 20 April 2026, providing investors with the latest insights into the company’s performance and outlook.

Zota Health Care Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 04 March 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 09 April 2026, providing investors with the latest insights into the company’s performance and outlook.

Zota Health Care Ltd has exhibited a notable shift in its technical momentum, moving from a bearish stance to a mildly bearish outlook, reflecting a complex interplay of technical indicators. Despite a robust day change of 7.14%, the stock’s mixed signals from MACD, RSI, moving averages, and other momentum indicators suggest cautious optimism amid underlying challenges in the Pharmaceuticals & Biotechnology sector.

Zota Health Care Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, with key indicators signalling a transition from mildly bearish to bearish trends. Despite a recent day gain of 3.68%, the company’s overall technical profile and fundamental scores suggest caution for investors amid mixed signals from MACD, RSI, moving averages, and other momentum indicators.

Zota Health Care Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, signalling increased bearishness. The stock’s recent price action, combined with deteriorating technical indicators, suggests mounting pressure on its near-term outlook despite its impressive long-term returns.

Zota Health Care Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 04 Mar 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 29 March 2026, providing investors with the latest insights into its performance and outlook.